The diabetes body project: Study protocol of a multi‐site trial of a virtually delivered eating disorder prevention program for young women with type 1 diabetes

Author:

Haugvik Severina12,Hennekes Mareille34,Stice Eric5,de Wit Maartje34ORCID,Toschi Elena6ORCID,Wisting Line12

Affiliation:

1. Oslo University Hospital Oslo Norway

2. Regional Department for Eating Disorders, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo Oslo Norway

3. Amsterdam UMC, Location Vrije Universiteit Amsterdam, Medical Psychology, de Boelelaan 1117 Amsterdam Netherlands

4. Amsterdam Public Health, Mental Health Amsterdam Netherlands

5. Department of Psychiatry and Behavioral Sciences Stanford University Stanford California USA

6. Joslin Diabetes Center, Harvard Medical School Boston Massachusetts USA

Abstract

AbstractAimYoung women with type 1 diabetes are a high‐risk population for eating disorders (ED). Prevention programs are lacking. In young women without diabetes, the Body Project has produced reductions in ED risk factors, ED symptoms and future ED onset. Therefore, the Body Project was adapted to type 1 diabetes, the Diabetes Body Project (DBP). In this protocol, we describe the multi‐site randomized controlled trial (RCT) to evaluate efficacy of the DBP.MethodsThis is an ongoing RCT with four sites (Europe and US). In total 280, 14–35 year‐old, women with type 1 diabetes ≥1 year and some level of body image concerns will be recruited in 2023. Participants are randomized to either virtual DBP groups or an educational control. The study constitutes 5 measurement points distributed over 2 years. The primary aim is to test if DBP will produce significantly greater reductions in ED behaviours, ED symptoms and future ED onset. The secondary aim is to test if DBP has significantly greater improvements in diabetes distress, quality of life and glycaemic outcomes.ResultsWe expect that DBP will be more efficacious in reducing ED behaviours, ED symptoms and ED onset compared to the control condition. Additionally, we hope to gain new knowledge on how DBP may affect diabetes‐related outcomes.ConclusionsIf DBP proves efficacious, it has potential for immediate, clinical implementation at low‐cost and may contribute to broad prevention of future ED onset among young women with type 1 diabetes.ClinicalTrials.gov Identifier: NCT05399446.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3